Keywords: Affymax, Takeda, Hematide, Milestone, Research results

Affymax gets $30 million milestone under Hematide accord with Takeda

Article | 23 June 2010

California, USA-based Affymax has received $30 million in development milestone payments from Japan’s largest drugmaker, Takeda Pharmaceutical, as part of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Affymax

Takeda Pharmaceuticals

Go to company listing

Related Drugs

Hematide

Go to drug listing